2025 MCM | New and Evolving Directions in the Treatment of HER2 Positive Breast Cancer

2025 MCM | New and Evolving Directions in the Treatment of HER2 Positive Breast Cancer

0% Complete

Course Content

This material is non-CME, no credits are available, and a certificate will not be provided upon completion.

Course Details

Duration
0.00 hour
Released
Jun 24, 2025
Last Review
Jun 24, 2025
Expires
Jun 24, 2026

Target Audience

Physicians

Nurses

Pharmacists

Physician Associates

Faculty & Disclosure

Faculty

Mark Pegram, MD

Disclosure

Mark Pegram, MD

Accreditation

NA